INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44m ago
HOUSE PTR3m ago
SEC 13F3m ago
ROBINHOOD CHAIN3m ago
Corporate insider
KN

Krishnamohan Neha

DirectorCIK 0001866171

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 2
Max Insider Score38
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
KN
Krishnamohan NehaDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise · 10b5-1 plan
M$233K
27.1K sh
Nov 13, 2025Nov 17, 2025
traded Nov 13, 2025
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Arcutis Biotherapeutics, Inc.Director · Nov 17, 2025
10
KN
Krishnamohan NehaDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise · 10b5-1 plan
M
$92K
12.2K sh
Nov 13, 2025
Nov 17, 2025
traded Nov 13, 2025
+4d
SEC FORM 4

Evidence

38
KN
Krishnamohan NehaDirector
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$911K
39.3K sh
Nov 13, 2025Nov 17, 2025
traded Nov 13, 2025
+4dSEC FORM 4

Evidence

24
KN
Krishnamohan NehaDirector
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
1,232 sh
Nov 13, 2025Nov 17, 2025
traded Nov 13, 2025
+4dSEC FORM 4

Evidence

0
KN
Krishnamohan NehaDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise · 10b5-1 plan
M—
12.2K sh
Nov 13, 2025Nov 17, 2025
traded Nov 13, 2025
+4dSEC FORM 4

Evidence

0
KN
Krishnamohan NehaDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise · 10b5-1 plan
M—
27.1K sh
Nov 13, 2025Nov 17, 2025
traded Nov 13, 2025
+4dSEC FORM 4

Evidence